Jennison Associates’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Jennison Associates's RGEN Position: Q2 2026 in Review
Jennison Associates reduced its Repligen (RGEN) stake by 38% in Q2 2026, selling an estimated $5.68M and leaving 74,996 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #390.
Jennison Associates first reported a position in RGEN in Q2 2017 and has held it in 22 quarters since. The position peaked at $37.5M in Q1 2021. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Jennison Associates held 74,996 shares of Repligen worth $10.2M as of Q2 2026.
- Jennison Associates sold 46,243 Repligen shares in Q2 2026, an estimated $5.68M.
- Repligen made up 0.01% of Jennison Associates's portfolio in Q2 2026, its #390 holding.
- Jennison Associates first reported a position in Repligen in Q2 2017 and has held it in 22 quarters since.
- Jennison Associates's Repligen position peaked at $37.5M in Q1 2021.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.